-
PBLS share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of PBLS shares has increased $0.65 since the market last closed. This is a 2.33% rise.
-
Closed at $28.53.
The stock has remained unchanged in after-hours trading.
Key terms
About PBLS
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
-
Market cap: $3.52B
A market capitalization between $2 billion and $10 billion places PBLS in the mid-capitalization category.
Key terms
Smart score
Latest PBLS news
PBLS Financials
-
PBLS total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
PBLS net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
PBLS earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
PBLS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PBLS Competitors
-
How competitors are chosen
PBLS's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
-
Market cap: $3.52B
A market capitalization between $2 billion and $10 billion places PBLS in the mid-capitalization category.
